Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers.

Park KS, Kim HS, Oh JH, Chung WC, Choi SC, Lee SH, Kim TH, Cheung DY, Baik GH, Kim SM, Lee HL, Moon JS, Choi CW, Sohn C, Kim KO, Kim BW, Jung HK, Jung DH, Kim SS, Park MI, Lee JY, Kim GH, Moon HS, Chun H, Shim KN, Shin WG, Park CH, Kim T, Jung SW, Kim H, Jee SR, Lee K, Cho YK, Park SC, Cho J, Huh C, Kwon H, Kim J, Kim J, Park JJ

Open source

DOI
10.5009/gnl250334
Published
2026 Jul 15
Container
Gut and liver
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5009/gnl250334,
  title = {Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers.},
  author = {Park KS and Kim HS and Oh JH and Chung WC and Choi SC and Lee SH and Kim TH and Cheung DY and Baik GH and Kim SM and Lee HL and Moon JS and Choi CW and Sohn C and Kim KO and Kim BW and Jung HK and Jung DH and Kim SS and Park MI and Lee JY and Kim GH and Moon HS and Chun H and Shim KN and Shin WG and Park CH and Kim T and Jung SW and Kim H and Jee SR and Lee K and Cho YK and Park SC and Cho J and Huh C and Kwon H and Kim J and Kim J and Park JJ},
  year = {2026},
  journal = {Gut and liver},
  doi = {10.5009/gnl250334},
  url = {https://doi.org/10.5009/gnl250334}
}

RIS

TY  - JOUR
TI  - Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers.
AU  - Park KS
AU  - Kim HS
AU  - Oh JH
AU  - Chung WC
AU  - Choi SC
AU  - Lee SH
AU  - Kim TH
AU  - Cheung DY
AU  - Baik GH
AU  - Kim SM
AU  - Lee HL
AU  - Moon JS
AU  - Choi CW
AU  - Sohn C
AU  - Kim KO
AU  - Kim BW
AU  - Jung HK
AU  - Jung DH
AU  - Kim SS
AU  - Park MI
AU  - Lee JY
AU  - Kim GH
AU  - Moon HS
AU  - Chun H
AU  - Shim KN
AU  - Shin WG
AU  - Park CH
AU  - Kim T
AU  - Jung SW
AU  - Kim H
AU  - Jee SR
AU  - Lee K
AU  - Cho YK
AU  - Park SC
AU  - Cho J
AU  - Huh C
AU  - Kwon H
AU  - Kim J
AU  - Kim J
AU  - Park JJ
PY  - 2026
JO  - Gut and liver
DO  - 10.5009/gnl250334
UR  - https://doi.org/10.5009/gnl250334
ER  - 

APA

KS, P., HS, K., JH, O., WC, C., SC, C., SH, L., TH, K., DY, C., GH, B., SM, K., HL, L., JS, M., CW, C., C, S., KO, K., BW, K., HK, J., DH, J., SS, K., MI, P., JY, L., GH, K., HS, M., H, C., KN, S., WG, S., CH, P., T, K., SW, J., H, K., SR, J., K, L., YK, C., SC, P., J, C., C, H., H, K., J, K., J, K., & JJ, P. (2026). Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers.. Gut and liver. https://doi.org/10.5009/gnl250334

Source records